Major Advancements in Slowing Diabetic Kidney Disease Progression: Focus on SGLT2 Inhibitors
Volume: 74, Issue: 5, Pages: 573 - 575
Published: Nov 1, 2019
Abstract
Diabetes is the most common cause of end-stage kidney disease, and its incidence and prevalence are projected to double by 2030.1Liyanage T. Ninomiya T. Jha V. et al.Worldwide access to treatment for end-stage kidney disease: a systematic review.Lancet. 2015; 385: 1975-1982Abstract Full Text Full Text PDF PubMed Scopus (794) Google Scholar During the past 3 decades, major studies to understand albuminuric kidney disease progression secondary to...
Paper Details
Title
Major Advancements in Slowing Diabetic Kidney Disease Progression: Focus on SGLT2 Inhibitors
Published Date
Nov 1, 2019
Volume
74
Issue
5
Pages
573 - 575
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History